Current Research into Cures for Type-1 Diabetes

I had previously reported here: http://cureresearch4type1diabetes.blogspot.com/2014/09/diapep277-development-canceled-due-to.html that Di...

This is the first paragraph from yesterday's press release from Hyperion: Hyperion Therapeutics, Inc. (HPTX) today announced it is te...

DiaVacs Starts a Phase-II Trial of Dendritic Cells ( DV-0100) DiaVacs is a newly created company with a goal of further developing the De...

Aldesleukin (Proleukin) Starts a Phase-II Clinical Trial Called DILD1T, this is a 40 person clinical trial.  It started in March 2013, and...

Prochymal Failed Phase-II Trials I missed this, when it was published back in May, but luckily Kelly Close (of Close Concerns, who publis...

Status of DiaPep277 The good news: DiaPep277 has finished one successful phase-III clinical trial, and is expected to finish enrollment of...

News About Diabetes News The biggest diabetes research meeting in the world is the American Diabetes Assoication (ADA) Science Sessions, w...

... but what does that mean?  Good News First This was a big (450+ people) study, and phase-III, so late in the processes of commerciali...

More News on Rituximab Background on the drug: Rituximab targets the CD20 part of the immune system's B cells (different from the pan...

I didn't quite get this out by the end of May, but it is the May update..... Andromedia Starts DIA-AID2: Second phase-III Trial of Di...